Drug intelligence / Profile preview

2-{[4-(trifluoromethoxy)benzoyl]amino}ethyl dihydrogen phosphate

Development stage: Unknown
Modality: Small Molecules

Overview

2-{[4-(trifluoromethoxy)benzoyl]amino}ethyl dihydrogen phosphate is an experimental small molecule compound belonging to the class of benzamides, characterized by a carboxamido substituent attached to a benzene ring. It has not been approved for use in any country and there are no known clinical trials or indications associated with it. The compound's precise mechanism of action, therapeutic target, and potential clinical applications have not been described in the available literature. Its molecular formula is C10H11F3NO6P and its DrugBank ID is DB07745[1][2].

Other names: 2-{[4-(trifluoromethoxy)benzoyl]amino}ethyl dihydrogen phosphate

Beyond the preview

Go deeper on 2-{[4-(trifluoromethoxy)benzoyl]amino}ethyl dihydrogen phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-{[4-(trifluoromethoxy)benzoyl]amino}ethyl dihydrogen phosphate.

Explore the full profile